His job is to sell the company to investors. Of course he is going to stay optimstic. The company knows if they write off these set of results they will not get another trial from the three hospitals and why they are running to the FDA with this set. Praying and hoping all the way there.
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-234
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #